Hytro BFR seeks investors for fitness industry expansion – Endurance.Biz

Hytro BFR (blood flow restriction), has announced a follow-on investment round to continue its growth in the strength and recovery market through its patented TechWear garments, which are claimed to increase muscle and speed up recovery.
The company points to a muscle growth and recovery market set to be worth US$5 billion by 2027.
After a successful funding round earlier in the year, Hytro is looking to secure an additional £1 million in early 2022. Hytros plan to use the capital to develop new products and expand the team after a fast growth period.
The brand claims to be ‘scientifically proven to increase muscle size by 31% and accelerate recovery time by 33%.’
‘Hytro’s BFR straps trap blood in the muscles causing them to swell and become stressed. This can increase muscle fibre activation and up-regulates muscle building hormones.’
Since launching, Hytro has been used by coaches, practitioners and athletes in elite sports including players from rugby league teams, Leeds Rhinos and St Helens.
The company states… ‘Mainstream media publications and national newspapers are tipping this as a rapidly growing trend amongst fitness enthusiasts, featuring Hytro as a pioneering brand delivering products to the consumer market.’
Raj Thiruchelvarajah, CEO and Co-Founder of Hytro, said “BFR training has been around for many years but has yet to go mainstream. The benefits are backed by a substantial body of research but the cumbersome products available have limited its use.
“At Hytro, we’re enabling everyone from elite athletes to newcomers to build muscle and recover faster with our safe and easy to use patented BFR TechWear. With sales and interest from some of the UK’s biggest professional sports teams, organisations and Olympians, we’re looking forward to continuing our journey to take BFR to the forefront of training.”